Nigellimine
CAS: 4594-02-9
Ref. 3D-EAA59402
| 1g | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
Nigellimine
Synonyms:
- 1-Methyl-6,7-dimethoxyisoquinoline
- Isoquinoline, 6,7-Dimethoxy-1-Methyl-
- Isosalsolidine
- Nigellicimine
- 6,7-Dimethoxy-1-methylisoquinoline
Description:
Nigellimine is a medicinal compound that has been shown to have potent anti-cancer properties. It is a kinase inhibitor that targets specific kinases involved in cancer cell proliferation and survival. Nigellimine is an analog of a compound found in Chinese black seed, and it has been shown to induce apoptosis (programmed cell death) in tumor cells. This compound has also demonstrated anticancer activity in animal studies, inhibiting the growth of cancer cells and reducing tumor size. Nigellimine is excreted in urine and has been shown to be safe for human consumption. Its potential as an anticancer therapy makes it a promising candidate for further research and development.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
203.24 g/mol
Formula:
C12H13NO2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
